SEARCH

SEARCH BY CITATION

References

  • 1
    Asou, N., Adachi, K., Tamura, J., Kanamaru, S., Kageyama, S., Hiraoka, A., Omoto, E., Akiyama, H., Tsubaki, K., Saito, K., Kuriyama, K., Oh, H., Kitano, K., Miyawaki, S., Takeyama, K., Yamada, O., Nishikawa, K., Takahashi, M., Matsuda, S., Ohtake, S., Suzushima, H., Emi, N., Ohno, R.. (1998) Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Journal of Clinical Oncology, 16, 78 85.
  • 2
    Den Boer, M.L., Zwaan, C.M., Pieters, R., Kazemier, K.M., Rottier, M.M.A., Flens, M.J., Scheper, R.J., Veerman A.J.P. (1997) Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia. Leukemia, 11, 1078 1085.
  • 3
    Dermine, S., Grignani, F., Clerici, M., Nervi, C., Sozzi, G., Talamo, G.P., Marcheshi, E., Formelli, F., Parmiani, G., Pelicci, P.G., Gambacorti-Passerrini C. (1993) Occurrence of resistance to retinoic acid in the acute promyelocytic leukemia cell line NB4 is associated with altered expression of the PML/RARα protein. Blood, 82, 1573 1577.
  • 4
    Hashimoto, Y., Kagechika, H., Kawachi, E., Fukazawa, H., Saito, G., Shudo K. (1995) Correlation of differentiation-inducing activity of retinoids on human leukemia cell lines HL60 and NB4. Journal of Cancer Research and Clinical Oncology, 121, 696 698.
  • 5
    Kahan J. (1967) The fluorescence properties of vitamin A and their changes during photodecomposition. Acta Chemica Scandinavica, 21, 2515 2524.
  • 6
    Kitamura, K., Kiyoi, H., Yoshida, H., Saito, H., Ohno, R., Naoe T. (1997) Mutant AF-2 domain of PML-RARα in retinoic acid-resistant NB4 cells: differentiation induced by RA is triggered directly through PML-RARα and its down-regulation in acute promyelocytic leukemia. Leukemia, 11, 1950 1956.
  • 7
    Kizaki, M., Ueno, H., Yamazoe, Y., Shimada, M., Takeyama, N., Muto, A., Matsushita, H., Nakajima, H., Morikawa, M., Koeffler, H.P., Ikeda Y. (1996) Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein. Blood, 87, 725 733.
  • 8
    Ohno, R., Yoshida, H., Fukutani, H., Naoe, T., Ohshima, T., Kyo, T., Endoh, N., Fujimoto, T., Kobayashi, T., Hiraoka, A., Mizoguchi, H., Kodera, Y., Suzuki, H., Hirano, M., Akiyama, H., Aoki, N., Shindo, H., Yokomaku, S.. (1993) Multi-institutional study of all-trans retinoic acid as differentiation therapy of refractory acute promyelocytic leukemia. Leukemia, 7, 1722 1727.
  • 9
    Su, G.M.I., Davey, M.W., Davey, R.A., Kidman A. (1994) Development of extended multidrug resistance in HL60 promyelocytic leukaemia cells. British Journal of Haematology, 88, 566 574.
  • 10
    Sugimoto, Y., Sato, S., Tsukahara, S., Suzuki, M., Okuchi, E., Gottesman, M.M., Pastan, I., Tsuruo T. (1997) Coexpression of multidrug resistance gene (MDR1) and herpes simplex virus thymidine kinase gene in a bicistronic retroviral vector Ha-MDR-IRES-TK allows selective killing of MDR1-transduced human tumors transplanted in nude mice. Cancer Gene Therapy, 4, 51 58.
  • 11
    Takeshita, A., Shinjo, K., Ohnishi, K., Ohno R. (1995) New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptavidin-RED670 conjugate. Japanese Journal of Cancer Research, 86, 607 615.
  • 12
    Takeshita, A., Shinjo, K., Ohnishi, K., Ohno R. (1996) Expression of multidrug resistance P-glycoprotein in myeloid progenitor cells of different phenotype: comparison between normal bone marrow cells and leukaemia cells. British Journal of Haematology, 93, 18 21.